Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.
about
An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree miceListening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes PathogenesisGut microbiota and immune crosstalk in metabolic diseaseLipopolysaccharide-binding protein is associated with arterial stiffness in patients with type 2 diabetes: a cross-sectional study.Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesityA gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulationIs butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?Markers of systemic exposures to products of intestinal bacteria in a dietary intervention study.Can We Prevent Obesity-Related Metabolic Diseases by Dietary Modulation of the Gut Microbiota?Serum LBP Is Associated with Insulin Resistance in Women with PCOS.Metabolomic insights into the intricate gut microbial-host interaction in the development of obesity and type 2 diabetes.Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments.Association of Lipopolysaccharide-Binding Protein With Aging-Related Adiposity Change and Prediabetes Among African Ancestry MenLipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents.Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primatesGut Endotoxin Leading to a Decline IN Gonadal function (GELDING) - a novel theory for the development of late onset hypogonadism in obese men.Microbial translocation and skeletal muscle in young and old vervet monkeysLipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity.The role of lipopolysaccharide-binding protein in innate immunity: a revisit and its relevance to oral/periodontal health.The possible role of antimicrobial proteins in obesity-associated immunologic alterations.Genetically obese mice do not show increased gut permeability or faecal bile acid hydrophobicity.Reliability of plasma lipopolysaccharide-binding protein (LBP) from repeated measures in healthy adultsStress induces endotoxemia and low-grade inflammation by increasing barrier permeability.Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood.Association of endotoxaemia with serum free fatty acids in metabolically healthy and unhealthy abdominally obese individuals: a case-control study in northwest of Iran.Reduced Intestinal Motility, Mucosal Barrier Function, and Inflammation in Aged Monkeys.Adipocyte lipopolysaccharide binding protein (LBP) is linked to a specific lipidomic signature.The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.[Gut microbiota and immune crosstalk in metabolic disease].Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.Lipopolysaccharide-binding protein cannot independently predict type 2 diabetes mellitus: A nested case-control study.Metabolic endotoxaemia--a potential novel link between ovarian inflammation and impaired progesterone production.Effect of caloric restriction on gut permeability, inflammation markers, and fecal microbiota in obese women.Involvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans.A role for adipocyte-derived lipopolysaccharide-binding protein in inflammation- and obesity-associated adipose tissue dysfunction.The Phospholipid Linoleoylglycerophosphocholine as a Biomarker of Directly Measured Insulin Resistance.Neuroinflammation in obesity: circulating lipopolysaccharide-binding protein associates with brain structure and cognitive performance.
P2860
Q24601321-44008FE3-735C-42BB-BADF-F13F58707DB3Q26823198-CEB8C5B1-1506-4CED-A89F-079B6C3A57A0Q28078180-FC876B1D-0AB2-4996-862E-BE4FB022F89EQ33655219-82EADB44-3C52-41FF-823D-8904CF9ABEF3Q34175068-7FF2D81A-31CB-43DF-9BA5-129E6419262CQ34629179-64DA175D-918F-4439-AE3F-845E495B6CF1Q34669782-87A3ACE3-DFF6-41F9-972B-456546339441Q34943068-C6F5AC7E-BA80-49BD-B3DA-E8565F92132EQ35611937-AEAFD562-64ED-46BB-AD4B-A6DF5CDEB82AQ35895693-F9D3F886-A5A7-47FC-88D7-184FC31A38FAQ35901379-49305AF4-ADC2-46BC-A5BA-1784EEB715CAQ36208733-F7633CD7-9F6D-4E69-AFF2-0709A2DD9FCAQ36224036-2016825B-FC00-4C44-9718-5FF2B13EA368Q36255749-069BAC87-E0DD-4748-B74A-E1EEDFBB0070Q36608408-D7DD3A50-22E4-4756-806E-95A1FBE52048Q36979176-D86F4923-2AFA-407B-A7C7-5BC19E7B5B9FQ37016475-441F5160-9E3B-46E2-9B99-AA4AAA03869EQ37031182-8AF0F02C-2FAE-4608-BCF5-F7B24BC50DF8Q37219662-2FF1D4EC-B8FD-419E-BE32-A1139106B02BQ37554733-8AA00FFD-B16F-4005-9214-94CA640F099CQ38100278-E025A128-19E4-4F02-82EA-8B38C505D992Q38206568-4220A3C1-B855-4DFE-8958-33529BD25DBCQ38317453-AA7CAEBE-9989-49E4-AF4C-0738FF0F8F22Q38379385-F0EF2E05-3541-45B3-9B84-54D677C76E45Q38510131-554F3779-87D4-41AE-8100-DC4D7948748DQ38687215-CED11C5E-110C-4A0C-B708-293073D3CF21Q38795221-D81B99E5-6A6E-4B1D-9DEB-D428FF3A1CA0Q38873846-CF3D61A2-575F-46F2-A70C-D5E4F326B2C6Q39301377-D91AE2B5-A063-4E61-895D-237C749AE2BDQ39994738-E01ECC89-1BFC-4B15-B965-BABCA30134CFQ40145683-871316F5-A238-4E80-BFE4-11749F26BCCEQ40705552-1AF23326-3561-47BB-8E26-F838F604640FQ41263976-442BC495-84A7-4AE0-A5CF-E7C82B1581C6Q41582774-48F42A02-3C93-4F1D-AE2D-4C504246F0A8Q41696821-70B96FC8-56AB-43C7-A112-0E1B1793F5FBQ42236515-3857D65A-0486-43BA-AB8F-EEF8AF6F6516Q42809506-933DFC8B-1856-4528-BC79-7DFDF5EEC53CQ42814704-BDF3FB02-A3B2-47CF-9CBF-9C3E32E48928Q47106148-6BAB4BE8-83C9-458E-90FB-E74131A6B373Q48207932-4DAD5764-0907-4EDD-A868-72EB829354B4
P2860
Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@ast
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@en
Circulating lipopolysaccharide-binding protein
@nl
type
label
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@ast
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@en
Circulating lipopolysaccharide-binding protein
@nl
prefLabel
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@ast
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@en
Circulating lipopolysaccharide-binding protein
@nl
P2093
P2860
P921
P356
P1476
Circulating lipopolysaccharide ...... ty-related insulin resistance.
@en
P2093
G Frühbeck
J M Fernández-Real
J M Moreno-Navarrete
J Salvador
R Burcelin
P2860
P2888
P304
P356
10.1038/IJO.2011.256
P407
P577
2011-12-20T00:00:00Z
P6179
1020490042